Infectious Diseases 1610 - Infectious Disease Alert - Oct 01, 2012

Target Audience:

This activity is intended for the infectious disease specialist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Stan Deresinski, MD, FACP, FIDSA
Clinical Professor of Medicine
Stanford University
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Section Editor Updates
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Timothy Jenkins, MD
Assistant Professor of Medicine
University of Colorado
Denver Health Medical Center

Associate Editors
Richard R. Watkins, MD, MS, FACP
Division of Infectious Diseases
Akron General Medical Center
Akron, OH
Associate Professor of Internal Medicine,
Northeast Ohio Medical University
Rootstown, OH

Dean L. Winslow, MD, FACP, FIDSA
Chairman, Department of Medicine
Santa Clara Valley, Medical Center
Clinical Professor of Medicine and Pediatrics
Division of Infectious Diseases and Geographic Medicine
Stanford University School of Medicine

Lin H. Chen, MD
Assistant Clinical Professor
Harvard Medical School
Director, Travel Medicine Center
Mt. Auburn Hospital
Cambridge, MA


  • The 'No Name Virus' in the Land of 'Those Who Kill': Hantavirus in Yosemite
  • Is Doxycycline Protective Against the Development of C. difficile infection?
  • New phlebovirus associated with severe febrile illness in Missouri
  • Thalidomide for IRIS? Optimal dose, duration unclear
  • Adequacy of Rabies Post-exposure Prophylaxis
  • Updates


  • discuss the diagnosis and treatment of infectious diseases
  • explain current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • discuss the latest information regarding risks, benefits and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases are transmitted and how such information can lead to the development of new therapies

Financial Disclosure:

Infectious Disease Alert's Editor, Stan Deresinski, MD, FACP, FIDSA, does research for the National Institutes of Health, and is an advisory board member and consultant for Merck. Updates Author Carol A. Kemper, MD, FACP, does research for Abbott Laboratories, and Merck. Peer Reviewer Timothy Jenkins, MD, and Associate Editor Richard R. Watkins, MD, MS, FACP, report no financial relationship relavent to this field of study. Associate Editor Dean L. Winslow, MD, FACP, FIDSA is a consultant for Siemens Diagnostic. Associate Editor Lin H. Chen, MD, has received research grants from the Centers for Disease Control and Prevention and Xcellerex.

Copyright 2012 AHC Media. All rights reserved.